Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04140552
Other study ID # CRGGC_LYB_2019
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2008
Est. completion date December 31, 2025

Study information

Verified date June 2021
Source Shanghai Jiao Tong University School of Medicine
Contact Yingbin Liu, MD, PhD
Phone +8613918803900
Email laoniulyb@163.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The Chinese Research Group of Gallbladder Cancer (CRGGC) is a retrospective multicenter registry cohort, collecting electronic medical records of patients diagnosed with gallbladder cancer from hospitals in collaboration.


Description:

The objectives of the CRGGC are as follows: 1. To study the current diagnosis and treatment of gallbladder cancer in China. 2. To clarify the prognostic role of debated risk factors associated with gallbladder cancer. 3. To improve the accurate staging of gallbladder cancer. 4. To standardize the treatment with gallbladder cancer.


Recruitment information / eligibility

Status Recruiting
Enrollment 10000
Est. completion date December 31, 2025
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients with at least clinical diagnosis of gallbladder cancer, including C23.9 and part of C24.0 (cystic duct cancer). - Patients with accessible electronic medical record Exclusion Criteria: - Patients with undetermined primary site of cancer.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Baotou City Central Hospital Baotou Inner Mongolia
China The First Affiliated Hospital of Bengbu Medical College Bengbu Anhui
China China-Japan Union Hospital of Jilin University Changchun Jilin
China The First Bethune Hospital of Jilin University Changchun Jilin
China The Second Hospital of Jilin University Changchun Jilin
China People's Hospital of Hunan Province Changsha Hunan
China Changshu No.1 People's Hospital Changshu Jiangsu
China Heping Hospital Affiliated to Changzhi Medical College Changzhi Shanxi
China Changzhou No.2 People's Hospital Changzhou Jiangsu
China The First Hospital of Lanzhou University Gansu Lanzhou
China Sir Run Run Shaw Hospital Hangzhou Zhejiang
China The Second Affiliated Hospital of Zhejiang University School of medicine Hangzhou Zhejiang
China Zhejiang Cancer Hospital Hangzhou Zhejiang
China Harbin Medical University Cancer Hospital Harbin Heilongjiang
China The First Affiliated Hospital of Harbin Medical University Harbin Heilongjiang
China The Second Affiliated Hospital of Harbin Medical University Harbin Heilongjiang
China Anhui Provincial Hospital Hefei Anhui
China The First Affiliated Hospital of Anhui Medical University Hefei Anhui
China Huzhou Central Hospital Huzhou Zhejiang
China The First Affiliated Hospital of Kunming Medical University Kunming Yunnan
China Jiangxi Provincial People's Hospital Nanchang Jiangxi
China The First Affiliated Hospital of Nanchang University Nanchang Jiangxi
China The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi
China Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School Nanjing Jiangsu
China Affiliated Hospital of Nantong University Nantong Jiangsu
China Nantong Tumor Hospital Nantong Jiangsu
China The First People's Hospital of Nantong Nantong Jiangsu
China Ningbo First Hospital Ningbo Zhejiang
China Yinzhou Hospital Affiliated to Medical School of Ningbo University Ningbo Zhejiang
China Central Hospital of Minhang District Shanghai Shanghai
China Eastern Hepatobiliary Surgery Hospital Shanghai Shanghai
China Putuo District People's Hospital of Shanghai Shanghai Shanghai
China Shanghai Fengxian District Central Hospital Shanghai Shanghai
China Shanghai General Hospital Shanghai Shanghai
China Shanghai Pudong Hospital Shanghai Shanghai
China Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai Shanghai
China Xinhua Hospital Shanghai Shanghai
China Zhongshan Hospital Shanghai Shanghai
China Shaoxing People's Hospital Shaoxing Zhejiang
China Shaoxing Second Hospital Shaoxing Zhejiang
China Shengjing Hospital of China Medical University Shenyang Liaoning
China The Second Affiliated Hospital of Suzhou University Suzhou Jiangsu
China The First People's Hospital of Taicang Taicang Jiangsu
China First Hospital of Shanxi Medical University Taiyuan Shanxi
China Shanxi Provincial Cancer Hospital Taiyuan Shanxi
China Tianjin Medical University Cancer Hospital Tianjin Tianjin
China The First Affiliated Hospital of Xinjiang Medical University Ürümqi Xinjiang
China The First Affiliated Hospital of Wenzhou Medical University Wenzhou Zhejiang
China Wuxi Second People's Hospital Wuxi Jiangsu
China The First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi
China Qinghai Provincial People's Hospital Xining Qinghai
China The Affiliated Hospital of Xuzhou Medical University Xuzhou Jiangsu
China Xuzhou Central Hospital Xuzhou Jiangsu
China Henan Cancer Hospital Zhengzhou Henan
China The Fifth Affiliated Hospital of Zhengzhou University Zhengzhou Henan

Sponsors (64)

Lead Sponsor Collaborator
Shanghai Jiao Tong University School of Medicine Affiliated Hospital of Nantong University, Anhui Provincial Hospital, Baotou Central Hospital, Central Hospital of Minhang District, Shanghai, Changzhi Medical College, Changzhou No.2 People's Hospital, China-Japan Union Hospital, Jilin University, Eastern Hepatobiliary Surgery Hospital, First Affiliated Hospital Bengbu Medical College, First Affiliated Hospital of Harbin Medical University, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Xinjiang Medical University, First Affiliated Hospital Xi'an Jiaotong University, Hainan People's Hospital, Harbin Medical University, Henan Cancer Hospital, Huizhou Municipal Central Hospital, Jiangxi Provincial Cancer Hospital, Jiangxi Provincial People's Hopital, LanZhou University, Ningbo No. 1 Hospital, People's Hospital of Hunan Province, Putuo District People's Hospital of Shanghai, Qilu Hospital of Shandong University, Qinghai People's Hospital, Second Affiliated Hospital of Nanchang University, Second Affiliated Hospital of Suzhou University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Second Hospital of Jilin University, Shandong Provincial Hospital, Shanghai Fengxian District Central Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Pudong Hospital, Shanghai Zhongshan Hospital, Shanxi Provincial Cancer Hospital, Shaoxing People's Hospital, Shaoxing Second Hospital, Shengjing Hospital, Sir Run Run Shaw Hospital, Taizhou Municipal Hospital, The Affiliated Hospital of Qingdao University, The Affiliated Hospital of Xuzhou Medical University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China, The First Affiliated Hospital of Anhui Medical University, The First Affiliated Hospital of Kunming Medical College, The First Affiliated Hospital of Nanchang University, The First Affiliated Hospital of Shanxi Medical University, The First Affiliated Hospital of Zhengzhou University, The First Hospital of Jilin University, The First People's Hospital of Changzhou, The First People's Hospital of Nantong, The First People's Hospital of Taicang, The Second Affiliated Hospital of Harbin Medical University, Tianjin Medical University Cancer Hospital, Tongliao City Hospital, Wuxi Second People's Hospital, Xijing Hospital, Xinghua City People's Hospital, Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Xuzhou Central Hospital, Yinzhou Hospital Affiliated to Medical School of Ningbo University, Zhejiang Cancer Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall Survival The overall survival data were defined by (date of death) - (date of first diagnosis). The survival status of patients were retrieved from follow-up. 5 years
See also
  Status Clinical Trial Phase
Recruiting NCT05007106 - MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) Phase 2
Completed NCT01053390 - New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma Phase 3
Completed NCT03510923 - Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy
Recruiting NCT05786716 - DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations Phase 2/Phase 3
Not yet recruiting NCT06276153 - Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer
Completed NCT06178848 - EEG Parameters Between Remimazolam- and Propofol-based Anesthesia N/A
Withdrawn NCT02174575 - Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery Phase 4
Completed NCT02430662 - Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms N/A
Completed NCT01242605 - ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer Phase 1